J0713 HCPCS code: Injection, ceftazidime, per 500 mg
J0713 is the HCPCS Level II code for injection, ceftazidime, per 500 mg. In 2024 Medicare paid an average of $1.29 per service for J0713 across 27,610 services. Its Medicare coverage code is D (Special coverage instructions apply): Medicare covers it when its national or local coverage criteria are met. The NCCI unit limit is 12 per day on outpatient hospital claims. Medicare volume rose 5% from 2022 to 2024 (26,384 to 27,610 services). In 2024, about 1,263 clinicians billed Medicare for J0713 for 2,347 beneficiaries; Florida, Georgia, Texas accounted for 76% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | D — Special coverage instructions apply |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 1996-01-01 |
| Last action effective | 1997-01-01 |
Who bills J0713 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 1,263 |
| Medicare beneficiaries | 2,347 |
| States with claims | 35 |
| Share of services in top 3 states (Florida, Georgia, Texas) | 76% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J0713, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 26,384 | 2,188 | $2.00 | $1.59 |
| 2023 | 24,078 | 2,424 | $1.73 | $1.37 |
| 2024 | 27,610 | 2,347 | $1.63 | $1.29 |
States with the most J0713 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 10,417 | $1.30 |
| Georgia | 8,906 | $1.29 |
| Texas | 1,506 | $1.29 |
| Oklahoma | 1,143 | $1.29 |
| New Jersey | 1,079 | $1.27 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 12 | Prescribing Information |
| practitioner claims | 12 | Clinical: Data |
What changed for J0713
- 1996-01-01: J0713 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J0713?
J0713 is the HCPCS Level II code for injection, ceftazidime, per 500 mg. Short descriptor: "Inj ceftazidime per 500 mg".
How much does Medicare pay for J0713?
In 2024, the average Medicare payment was $1.29 per service (average allowed $1.63).
Does Medicare cover J0713?
Coverage code D — Special coverage instructions apply. Medicare covers it when its national or local coverage criteria are met.
How many units of J0713 can be billed per day?
12 on outpatient hospital claims; 12 on practitioner claims (NCCI medically unlikely edits).
Related J07 codes
- J0701 — Injection, cefepime hydrochloride (baxter), not therapeutically equivalent to maxipime, 500 mg
- J0702 — Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg
- J0703 — Injection, cefepime hydrochloride (b braun), not therapeutically equivalent to maxipime, 500 mg
- J0706 — Injection, caffeine citrate, 5 mg
- J0710 — Injection, cephapirin sodium, up to 1 gm
- J0712 — Injection, ceftaroline fosamil, 10 mg
- J0714 — Injection, ceftazidime and avibactam, 0.5 g/0.125 g
- J0715 — Injection, ceftizoxime sodium, per 500 mg
- J0716 — Injection, centruroides immune f(ab)2, up to 120 milligrams
- J0717 — Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)
- J0720 — Injection, chloramphenicol sodium succinate, up to 1 gm
- J0725 — Injection, chorionic gonadotropin, per 1,000 usp units
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J0713
- Watch J0713 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J0713
Sources: CMS HCPCS Level II release October 2026; CMS DMEPOS fee schedule; CMS NCCI MUE tables; CMS Medicare utilization (physician and DME supplier files); CMS Medicare Coverage Database articles. Fees are Medicare allowables, not commercial rates. Not billing or legal advice.